Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you live in Colchester and are considering weight loss injections, the clearest starting point is this: both Mounjaro (tirzepatide) and Wegovy (semaglutide) are prescription-only medicines, available only after a clinical assessment confirms they are right for you. Neither is sold over the counter, and your postcode does not determine your access to a regulated private service. A GPhC-registered online pharmacy can legally supply these medicines anywhere in England, including Colchester, once a qualified prescriber has reviewed your case and issued a prescription. What varies by location is whether your local NHS practice or specialist service is currently prescribing them — and for most people in Colchester right now, that waiting list is long.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro and Wegovy work by mimicking hormones your gut naturally releases after eating. Wegovy contains semaglutide, a GLP-1 receptor agonist that signals fullness to the brain and slows the rate at which food leaves the stomach. Mounjaro contains tirzepatide, which activates both the GLP-1 and GIP receptors, making it the only dual-agonist weight loss medicine licensed in the UK. Both lead to a reduced appetite and, when combined with a lower-calorie diet and more activity, meaningful reductions in body weight over time.
The clinical evidence behind these medicines is substantial. The SURMOUNT-1 trial, published in the New England Journal of Medicine, found that tirzepatide produced an average body-weight reduction of around 20–21% over 72 weeks at the highest dose. Semaglutide 2.4mg produced around 15% average reduction in the STEP 1 trial. Those are averages from thousands of trial participants, individual results vary, and no clinical service can guarantee a specific outcome for any one person.
If you want a more detailed breakdown of what happens at each stage of treatment, this page explains exactly what the injection does from the first dose onward.
NHS access to these medicines is being rolled out in carefully defined phases across England, and your local integrated care board's position matters. As of summer 2026, NHS tirzepatide is available to adults with a BMI of 40 or above alongside four or more qualifying conditions (high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, or type 2 diabetes), with a second cohort (BMI 35–39.9 with four or more conditions) activated in June 2026. GP practices may prescribe under the updated GP contract, but participation varies by practice, so availability across the Colchester area is not uniform.
Wegovy via the NHS requires referral to a specialist weight management service under NICE guidance TA875, and waiting lists for those services are commonly long. For people who do not meet the current NHS criteria, or who would rather not wait, a regulated private online pharmacy is a legal alternative, accessible to anyone in Colchester with an internet connection and a qualifying BMI. The full overview of licensed weight loss injections in the UK sets out both routes clearly.
Residents in other parts of the country face the same picture. Colleagues in cities like Manchester, Leicester, and Doncaster are navigating identical NHS phasing, the private route exists for the same reason everywhere.
The most common side effects with both injections are gastrointestinal: nausea, constipation, diarrhoea, indigestion, and burping are all reported, and fatigue or mild headaches can occur particularly in the first weeks. For most people these symptoms are at their worst shortly after starting or after a dose increase, then gradually ease. Staying well hydrated helps, as does eating smaller portions slowly.
Less common but more serious effects require prompt medical attention. A January 2026 Drug Safety Update from the MHRA highlighted acute pancreatitis as an infrequent but potentially serious risk: severe stomach pain that reaches through to the back, with or without vomiting, is the warning sign. If that happens, stop the injection and go to A&E or call 999. You can also report suspected side effects via the MHRA Yellow Card scheme, which helps regulators monitor medicines in real-world use.
People using oral contraceptives who are prescribed tirzepatide should be aware that pill absorption may be reduced for the first four weeks of treatment and for four weeks after each dose increase, a non-oral method of contraception is recommended during those windows. Your prescriber will discuss this at assessment. Full side-effect information is always in the Patient Information Leaflet that comes with your medication.
The process through a regulated online pharmacy is straightforward and does not require you to travel anywhere. You complete a clinical consultation (covering your health history, current medicines, BMI, and any relevant conditions) and a GPhC-registered Independent Prescriber reviews it personally. At nume, that review happens the same day. There is no algorithm making the call; a named clinician reads your answers.
If treatment is clinically suitable, identity and weight are verified, and your prescription is issued. Order before 12pm on a working day and your medication is dispatched the same day, arriving free the next working day via DPD tracked delivery, in plain unbranded packaging. There is no subscription and no auto-renewal; each repeat order goes through a fresh clinical review. You can check our GPhC pharmacy registration (number 9012878) directly on the GPhC register.
Some people order on a Monday after payday, which works well with the same-day dispatch cut-off, worth knowing if you are timing your first order around your finances. Pricing for treatment is shown on the consultation and treatment page, alongside what the one transparent price covers. Our clinical team oversees every prescription; more about how the service is run is on our about us page.
If you are new to the idea of getting a prescription online, this guide to obtaining weight loss injections in the UK walks through the legal requirements and what makes a provider trustworthy.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.